MOLECULAR PARTNERS ADS/1 (6ML0) — Capital Reinvestment Ratio
MOLECULAR PARTNERS ADS/1 (6ML0) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (€118.57 Million) in capital expenditures (€1.42 Million). See MOLECULAR PARTNERS ADS/1 balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
MOLECULAR PARTNERS ADS/1 Capital Reinvestment Ratio (2022–2022)
This chart tracks MOLECULAR PARTNERS ADS/1's Capital Reinvestment Ratio across 1 annual periods. Check MOLECULAR PARTNERS ADS/1 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for MOLECULAR PARTNERS ADS/1 (2022–2022)
Year-by-year Capital Reinvestment Ratio for MOLECULAR PARTNERS ADS/1 from 2022 to 2022. For live market cap and broader valuation context, see MOLECULAR PARTNERS ADS/1 stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | €118.57 Million | €1.42 Million | — |